Unit-2 of Apitoria Pharma Private Limited a wholly owned subsidiary of the Company received Establishment Inspection Report from US FDA with classification as "Voluntary Action Indicated".
Aurobindo Pharma: Apitoria Unit 2 An API Manufacturing Facility Of Apitoria Pharma Private Limited. A Subsidiary Of The Company Receives Establishment Inspection Report From US FDA With Classification As 'Voluntary Action Indicated'
November 11, 2026
Download PDF
Aurobindo Pharma
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month